TreeWAS – Variant ID: rs11773966

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
R31 Unspecified haematuria	0.034	0.966	0.000
R30-R39 Symptoms and signs involving the urinary system	0.029	0.971	0.000
R33 Retention of urine	0.029	0.971	0.000
R35 Polyuria	0.025	0.975	0.000
R32 Unspecified urinary incontinence	0.022	0.978	0.000
R34 Anuria and oliguria	0.022	0.978	0.000
R36 Urethral discharge	0.021	0.979	0.000
R39 Other symptoms and signs involving the urinary system	0.021	0.979	0.000
R39.1 Other difficulties with micturition	0.018	0.982	0.000
R30 Pain associated with micturition	0.016	0.984	0.000
E03.9 Hypothyroidism, unspecified	0.000	0.984	0.016
R39.2 Extrarenal uraemia	0.015	0.985	0.000
R39.0 Extravasation of urine	0.014	0.986	0.000
R39.8 Other and unspecified symptoms and signs involving the urinary system	0.013	0.987	0.000
R30.1 Vesical tenesmus	0.012	0.988	0.000
R30.9 Painful micturition, unspecified	0.011	0.989	0.000
E03 Other hypothyroidism	0.000	0.989	0.011
N40 Hyperplasia of prostate	0.009	0.991	0.000
E03.8 Other specified hypothyroidism	0.000	0.991	0.008
E03.5 Myxoedema coma	0.000	0.992	0.008
E03.4 Atrophy of thyroid (acquired)	0.000	0.992	0.008
E03.3 Postinfectious hypothyroidism	0.000	0.992	0.008
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.000	0.992	0.008
E03.0 Congenital hypothyroidism with diffuse goitre	0.000	0.992	0.008
E03.1 Congenital hypothyroidism without goitre	0.000	0.992	0.008
N50.8 Other specified disorders of male genital organs	0.008	0.992	0.000
R30.0 Dysuria	0.007	0.992	0.000
N40-N51 Diseases of male genital organs	0.007	0.993	0.000
N50 Other disorders of male genital organs	0.007	0.993	0.000
N43 Hydrocele and spermatocele	0.007	0.993	0.000
E00-E07 Disorders of thyroid gland	0.000	0.993	0.007
N43.3 Hydrocele, unspecified	0.007	0.993	0.000
E04 Other non-toxic goitre	0.000	0.994	0.006
N45 Orchitis and epididymitis	0.006	0.994	0.000
N42 Other disorders of prostate	0.005	0.995	0.000
N44 Torsion of testis	0.005	0.995	0.000
N46 Male infertility	0.005	0.995	0.000
N43.4 Spermatocele	0.005	0.995	0.000
N50.0 Atrophy of testis	0.005	0.995	0.000
N43.2 Other hydrocele	0.005	0.995	0.000
N49 Inflammatory disorders of male genital organs, not elsewhere classified	0.005	0.995	0.000
N43.1 Infected hydrocele	0.005	0.995	0.000
N51 Disorders of male genital organs in diseases classified elsewhere	0.005	0.995	0.000
E04.2 Non-toxic multinodular goitre	0.000	0.995	0.005
N48 Other disorders of penis	0.005	0.995	0.000
N43.0 Encysted hydrocele	0.005	0.995	0.000
E04.1 Non-toxic single thyroid nodule	0.000	0.995	0.005
E02 Subclinical iodine-deficiency hypothyroidism	0.000	0.995	0.005
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.995	0.005
E00 Congenital iodine-deficiency syndrome	0.000	0.995	0.005
N50.9 Disorder of male genital organs, unspecified	0.005	0.995	0.000
E06 Thyroiditis	0.000	0.995	0.005
E05 Thyrotoxicosis [hyperthyroidism]	0.000	0.995	0.005
I44.7 Left bundle-branch block, unspecified	0.005	0.995	0.000
E27 Other disorders of adrenal gland	0.000	0.995	0.005
N47 Redundant prepuce, phimosis and paraphimosis	0.005	0.995	0.000
E04.8 Other specified non-toxic goitre	0.000	0.995	0.004
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.995	0.004
N42.0 Calculus of prostate	0.004	0.995	0.000
E27.1 Primary adrenocortical insufficiency	0.000	0.995	0.004
N45.0 Orchitis, epididymitis and epididymo-orchitis with abscess	0.004	0.995	0.000
N45.9 Orchitis, epididymitis and epididymo-orchitis without abscess	0.004	0.996	0.000
E04.0 Non-toxic diffuse goitre	0.000	0.996	0.004
R26.8 Other and unspecified abnormalities of gait and mobility	0.004	0.996	0.000
E04.9 Non-toxic goitre, unspecified	0.000	0.996	0.004
R29.8 Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems	0.004	0.996	0.000
N42.8 Other specified disorders of prostate	0.004	0.996	0.000
N42.2 Atrophy of prostate	0.004	0.996	0.000
N42.3 Dysplasia of prostate	0.004	0.996	0.000
N48.4 Impotence of organic origin	0.004	0.996	0.000
E20-E35 Disorders of other endocrine glands	0.000	0.996	0.004
N42.1 Congestion and haemorrhage of prostate	0.004	0.996	0.000
N48.5 Ulcer of penis	0.004	0.996	0.000
N48.6 Balanitis xerotica obliterans	0.004	0.996	0.000
E07 Other disorders of thyroid	0.000	0.996	0.004
E05.8 Other thyrotoxicosis	0.000	0.996	0.004
N48.3 Priapism	0.004	0.996	0.000
N49.2 Inflammatory disorders of scrotum	0.004	0.996	0.000
N41 Inflammatory diseases of prostate	0.004	0.996	0.000
N48.2 Other inflammatory disorders of penis	0.004	0.996	0.000
N48.1 Balanoposthitis	0.004	0.996	0.000
N49.9 Inflammatory disorder of unspecified male genital organ	0.004	0.996	0.000
N49.0 Inflammatory disorders of seminal vesicle	0.004	0.996	0.000
N51.8 Other disorders of male genital organs in diseases classified elsewhere	0.004	0.996	0.000
N51.1 Disorders of testis and epididymis in diseases classified elsewhere	0.004	0.996	0.000
N51.0 Disorders of prostate in diseases classified elsewhere	0.004	0.996	0.000
N48.9 Disorder of penis, unspecified	0.004	0.996	0.000
N49.8 Inflammatory disorders of other specified male genital organs	0.004	0.996	0.000
N48.0 Leukoplakia of penis	0.004	0.996	0.000
I21.9 Acute myocardial infarction, unspecified	0.004	0.996	0.000
N50.1 Vascular disorders of male genital organs	0.004	0.996	0.000
N51.2 Balanitis in diseases classified elsewhere	0.004	0.996	0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.000	0.996	0.004
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.000	0.996	0.004
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.000	0.996	0.004
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.000	0.996	0.004
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.996	0.004
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.000	0.996	0.004
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.000	0.996	0.004
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.000	0.996	0.004
N49.1 Inflammatory disorders of spermatic cord, tunica vaginalis and vas deferens	0.004	0.996	0.000
E24 Cushing's syndrome	0.000	0.996	0.004
E06.5 Other chronic thyroiditis	0.000	0.996	0.004
E05.0 Thyrotoxicosis with diffuse goitre	0.000	0.996	0.004
E06.3 Autoimmune thyroiditis	0.000	0.996	0.004
E27.2 Addisonian crisis	0.000	0.996	0.004
E06.4 Drug-induced thyroiditis	0.000	0.996	0.004
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.000	0.996	0.004
E06.0 Acute thyroiditis	0.000	0.996	0.004
E05.5 Thyroid crisis or storm	0.000	0.996	0.004
E05.4 Thyrotoxicosis factitia	0.000	0.996	0.004
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.000	0.996	0.004
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.000	0.996	0.004
E06.1 Subacute thyroiditis	0.000	0.996	0.004
R26 Abnormalities of gait and mobility	0.004	0.996	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.000	0.996	0.003
E27.5 Adrenomedullary hyperfunction	0.000	0.996	0.003
E27.0 Other adrenocortical overactivity	0.000	0.996	0.003
E27.9 Disorder of adrenal gland, unspecified	0.000	0.996	0.003
E06.9 Thyroiditis, unspecified	0.000	0.996	0.003
E27.8 Other specified disorders of adrenal gland	0.000	0.996	0.003
R29 Other symptoms and signs involving the nervous and musculoskeletal systems	0.004	0.996	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.000	0.996	0.003
N42.9 Disorder of prostate, unspecified	0.003	0.996	0.000
E24.9 Cushing's syndrome, unspecified	0.000	0.997	0.003
E20 Hypoparathyroidism	0.000	0.997	0.003
I63.9 Cerebral infarction, unspecified	0.003	0.997	0.000
R25-R29 Symptoms and signs involving the nervous and musculoskeletal systems	0.003	0.997	0.000
E34 Other endocrine disorders	0.000	0.997	0.003
E22 Hyperfunction of pituitary gland	0.000	0.997	0.003
E05.9 Thyrotoxicosis, unspecified	0.000	0.997	0.003
E24.0 Pituitary-dependent Cushing's disease	0.000	0.997	0.003
E32 Diseases of thymus	0.000	0.997	0.003
E26 Hyperaldosteronism	0.000	0.997	0.003
Chapter IV Endocrine, nutritional and metabolic diseases	0.000	0.997	0.003
E35 Disorders of endocrine glands in diseases classified elsewhere	0.000	0.997	0.003
E30 Disorders of puberty, not elsewhere classified	0.000	0.997	0.003
E31 Polyglandular dysfunction	0.000	0.997	0.003
E29 Testicular dysfunction	0.000	0.997	0.003
E25 Adrenogenital disorders	0.000	0.997	0.003
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.000	0.997	0.003
E07.1 Dyshormogenetic goitre	0.000	0.997	0.003
E07.0 Hypersecretion of calcitonin	0.000	0.997	0.003
E24.2 Drug-induced Cushing's syndrome	0.000	0.997	0.003
R00.1 Bradycardia, unspecified	0.000	0.997	0.003
N41.3 Prostatocystitis	0.003	0.997	0.000
N41.0 Acute prostatitis	0.003	0.997	0.000
R26.3 Immobility	0.003	0.997	0.000
N41.2 Abscess of prostate	0.003	0.997	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.000	0.997	0.003
E24.3 Ectopic ACTH syndrome	0.000	0.997	0.003
E24.1 Nelson's syndrome	0.000	0.997	0.003
N48.8 Other specified disorders of penis	0.003	0.997	0.000
E23 Hypofunction and other disorders of pituitary gland	0.000	0.997	0.003
E07.8 Other specified disorders of thyroid	0.000	0.997	0.003
E24.8 Other Cushing's syndrome	0.000	0.997	0.003
N41.1 Chronic prostatitis	0.003	0.997	0.000
N41.8 Other inflammatory diseases of prostate	0.003	0.997	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.000	0.997	0.003
E34.9 Endocrine disorder, unspecified	0.000	0.997	0.003
E50-E64 Other nutritional deficiencies	0.000	0.997	0.003
Z80.0 Family history of malignant neoplasm of digestive organs	0.003	0.997	0.000
R06.0 Dyspnoea	0.003	0.997	0.000
R26.1 Paralytic gait	0.003	0.997	0.000
E28 Ovarian dysfunction	0.000	0.997	0.003
R27 Other lack of coordination	0.003	0.997	0.000
R26.0 Ataxic gait	0.003	0.997	0.000
E20.9 Hypoparathyroidism, unspecified	0.000	0.997	0.003
R25 Abnormal involuntary movements	0.003	0.997	0.000
R29.1 Meningismus	0.003	0.997	0.000
E20.1 Pseudohypoparathyroidism	0.000	0.997	0.003
R29.0 Tetany	0.003	0.997	0.000
I21 Acute myocardial infarction	0.003	0.997	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.000	0.997	0.003
R29.4 Clicking hip	0.003	0.997	0.000
R29.3 Abnormal posture	0.003	0.997	0.000
E55 Vitamin D deficiency	0.000	0.997	0.003
E40-E46 Malnutrition	0.000	0.997	0.003
E20.0 Idiopathic hypoparathyroidism	0.000	0.997	0.003
R29.2 Abnormal reflex	0.003	0.997	0.000
E21.0 Primary hyperparathyroidism	0.000	0.997	0.003
E26.0 Primary hyperaldosteronism	0.000	0.997	0.003
E32.9 Disease of thymus, unspecified	0.000	0.997	0.003
E20.8 Other hypoparathyroidism	0.000	0.997	0.003
E22.8 Other hyperfunction of pituitary gland	0.000	0.997	0.003
E22.0 Acromegaly and pituitary gigantism	0.000	0.997	0.003
E34.8 Other specified endocrine disorders	0.000	0.997	0.003
E34.5 Androgen resistance syndrome	0.000	0.997	0.003
E34.4 Constitutional tall stature	0.000	0.997	0.003
E34.2 Ectopic hormone secretion, not elsewhere classified	0.000	0.997	0.003
E34.1 Other hypersecretion of intestinal hormones	0.000	0.997	0.003
E55.9 Vitamin D deficiency, unspecified	0.000	0.997	0.003
E22.9 Hyperfunction of pituitary gland, unspecified	0.000	0.997	0.002
E34.3 Short stature, not elsewhere classified	0.000	0.997	0.002
E26.8 Other hyperaldosteronism	0.000	0.997	0.002
E26.1 Secondary hyperaldosteronism	0.000	0.997	0.002
E32.1 Abscess of thymus	0.000	0.997	0.002
E32.0 Persistent hyperplasia of thymus	0.000	0.997	0.002
E32.8 Other diseases of thymus	0.000	0.997	0.002
E26.9 Hyperaldosteronism, unspecified	0.000	0.997	0.002
R25.2 Cramp and spasm	0.003	0.997	0.000
R26.2 Difficulty in walking, not elsewhere classified	0.002	0.997	0.000
E30.9 Disorder of puberty, unspecified	0.000	0.997	0.002
E30.8 Other disorders of puberty	0.000	0.997	0.002
E30.1 Precocious puberty	0.000	0.997	0.002
E30.0 Delayed puberty	0.000	0.997	0.002
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.000	0.997	0.002
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.000	0.997	0.002
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.000	0.997	0.002
I63 Cerebral infarction	0.003	0.997	0.000
E29.8 Other testicular dysfunction	0.000	0.997	0.002
E29.0 Testicular hyperfunction	0.000	0.997	0.002
E31.9 Polyglandular dysfunction, unspecified	0.000	0.997	0.002
E31.8 Other polyglandular dysfunction	0.000	0.997	0.002
E31.1 Polyglandular hyperfunction	0.000	0.997	0.002
E07.9 Disorder of thyroid, unspecified	0.001	0.997	0.002
E25.9 Adrenogenital disorder, unspecified	0.000	0.997	0.002
E25.8 Other adrenogenital disorders	0.000	0.997	0.002
E34.0 Carcinoid syndrome	0.000	0.997	0.002
R01.1 Cardiac murmur, unspecified	0.003	0.997	0.000
E29.9 Testicular dysfunction, unspecified	0.000	0.997	0.002
E29.1 Testicular hypofunction	0.000	0.997	0.002
E31.0 Autoimmune polyglandular failure	0.000	0.997	0.002
N41.9 Inflammatory disease of prostate, unspecified	0.002	0.997	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.997	0.003
E21.4 Other specified disorders of parathyroid gland	0.000	0.997	0.002
E21.2 Other hyperparathyroidism	0.000	0.997	0.002
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.000	0.997	0.002
E21.5 Disorder of parathyroid gland, unspecified	0.000	0.997	0.002
E22.1 Hyperprolactinaemia	0.000	0.997	0.002
E23.6 Other disorders of pituitary gland	0.000	0.997	0.002
E61 Deficiency of other nutrient elements	0.000	0.997	0.002
R27.8 Other and unspecified lack of coordination	0.002	0.997	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.997	0.002
T39.1 4-Aminophenol derivatives	0.000	0.997	0.002
I44 Atrioventricular and left bundle-branch block	0.002	0.997	0.000
E10-E14 Diabetes mellitus	0.000	0.997	0.003
E23.2 Diabetes insipidus	0.000	0.997	0.002
E54 Ascorbic acid deficiency	0.000	0.997	0.002
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.000	0.997	0.002
E23.1 Drug-induced hypopituitarism	0.000	0.997	0.002
I08.1 Disorders of both mitral and tricuspid valves	0.002	0.997	0.000
E46 Unspecified protein-energy malnutrition	0.000	0.998	0.002
E51 Thiamine deficiency	0.000	0.998	0.002
E23.7 Disorder of pituitary gland, unspecified	0.000	0.998	0.002
I08 Multiple valve diseases	0.002	0.998	0.000
E64 Sequelae of malnutrition and other nutritional deficiencies	0.000	0.998	0.002
E50 Vitamin A deficiency	0.000	0.998	0.002
E60 Dietary zinc deficiency	0.000	0.998	0.002
E59 Dietary selenium deficiency	0.000	0.998	0.002
E52 Niacin deficiency [pellagra]	0.000	0.998	0.002
I21.0 Acute transmural myocardial infarction of anterior wall	0.002	0.998	0.000
E63 Other nutritional deficiencies	0.000	0.998	0.002
E28.9 Ovarian dysfunction, unspecified	0.000	0.998	0.002
E28.8 Other ovarian dysfunction	0.000	0.998	0.002
E28.1 Androgen excess	0.000	0.998	0.002
E28.0 Oestrogen excess	0.000	0.998	0.002
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.002	0.998	0.000
R27.0 Ataxia, unspecified	0.002	0.998	0.000
E14 Unspecified diabetes mellitus	0.000	0.998	0.002
E56 Other vitamin deficiencies	0.000	0.998	0.002
R59.0 Localised enlarged lymph nodes	0.002	0.998	0.000
E58 Dietary calcium deficiency	0.000	0.998	0.002
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.000	0.998	0.002
E28.3 Primary ovarian failure	0.000	0.998	0.002
R25.3 Fasciculation	0.002	0.998	0.000
I21.3 Acute transmural myocardial infarction of unspecified site	0.002	0.998	0.000
R25.0 Abnormal head movements	0.002	0.998	0.000
I21.X Presumed acute myicardial infaction (unconfirmed)	0.002	0.998	0.000
I63.8 Other cerebral infarction	0.002	0.998	0.000
I21.1 Acute transmural myocardial infarction of inferior wall	0.002	0.998	0.000
R25.8 Other and unspecified abnormal involuntary movements	0.002	0.998	0.000
Z35.5 Supervision of elderly primigravida	0.000	0.998	0.002
E55.0 Rickets, active	0.000	0.998	0.002
E44 Protein-energy malnutrition of moderate and mild degree	0.000	0.998	0.002
E45 Retarded development following protein-energy malnutrition	0.000	0.998	0.002
E43 Unspecified severe protein-energy malnutrition	0.000	0.998	0.002
E42 Marasmic kwashiorkor	0.000	0.998	0.002
E41 Nutritional marasmus	0.000	0.998	0.002
E40 Kwashiorkor	0.000	0.998	0.002
I44.1 Atrioventricular block, second degree	0.002	0.998	0.000
H35.0 Background retinopathy and retinal vascular changes	0.000	0.998	0.002
E53 Deficiency of other B group vitamins	0.000	0.998	0.002
E14.3 With ophthalmic complications	0.000	0.998	0.002
E13 Other specified diabetes mellitus	0.000	0.998	0.002
E21.3 Hyperparathyroidism, unspecified	0.000	0.998	0.002
E23.0 Hypopituitarism	0.000	0.998	0.002
I63.0 Cerebral infarction due to thrombosis of precerebral arteries	0.002	0.998	0.000
M20.1 Hallux valgus (acquired)	0.000	0.998	0.002
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.998	0.002
H35 Other retinal disorders	0.000	0.998	0.002
I47.1 Supraventricular tachycardia	0.002	0.998	0.000
I50.0 Congestive heart failure	0.002	0.998	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.998	0.002
E14.9 Without complications	0.000	0.998	0.002
E61.1 Iron deficiency	0.000	0.998	0.002
H35.5 Hereditary retinal dystrophy	0.000	0.998	0.002
I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic	0.002	0.998	0.000
I63.4 Cerebral infarction due to embolism of cerebral arteries	0.002	0.998	0.000
R25.1 Tremor, unspecified	0.002	0.998	0.000
I24 Other acute ischaemic heart diseases	0.002	0.998	0.000
I63.1 Cerebral infarction due to embolism of precerebral arteries	0.002	0.998	0.000
T39.0 Salicylates	0.000	0.998	0.002
E28.2 Polycystic ovarian syndrome	0.000	0.998	0.002
I21.2 Acute transmural myocardial infarction of other sites	0.002	0.998	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.998	0.002
I05-I09 Chronic rheumatic heart diseases	0.002	0.998	0.000
T39.4 Antirheumatics, not elsewhere classified	0.000	0.998	0.002
T39.2 Pyrazolone derivatives	0.000	0.998	0.002
E61.2 Magnesium deficiency	0.000	0.998	0.002
I44.4 Left anterior fascicular block	0.002	0.998	0.000
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries	0.002	0.998	0.000
I63.2 Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries	0.002	0.998	0.000
K76.8 Other specified diseases of liver	0.002	0.998	0.000
T43.2 Other and unspecified antidepressants	0.000	0.998	0.002
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.998	0.002
E14.6 With other specified complications	0.000	0.998	0.002
E61.9 Deficiency of nutrient element, unspecified	0.000	0.998	0.002
E61.8 Deficiency of other specified nutrient elements	0.000	0.998	0.002
E61.7 Deficiency of multiple nutrient elements	0.000	0.998	0.002
E61.6 Vanadium deficiency	0.000	0.998	0.002
E61.5 Molybdenum deficiency	0.000	0.998	0.002
E61.4 Chromium deficiency	0.000	0.998	0.002
E61.3 Manganese deficiency	0.000	0.998	0.002
E61.0 Copper deficiency	0.000	0.998	0.002
I20-I25 Ischaemic heart diseases	0.002	0.998	0.000
I44.5 Left posterior fascicular block	0.002	0.998	0.000
I63.3 Cerebral infarction due to thrombosis of cerebral arteries	0.002	0.998	0.000
E51.2 Wernicke's encephalopathy	0.000	0.998	0.002
I08.9 Multiple valve disease, unspecified	0.002	0.998	0.000
I21.4 Acute subendocardial myocardial infarction	0.002	0.998	0.000
R29.6 Tendency to fall, not elsewhere classified	0.002	0.998	0.000
E12 Malnutrition-related diabetes mellitus	0.000	0.998	0.002
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.002	0.998	0.000
E51.9 Thiamine deficiency, unspecified	0.000	0.998	0.002
E51.8 Other manifestations of thiamine deficiency	0.000	0.998	0.002
E51.1 Beriberi	0.000	0.998	0.002
I08.8 Other multiple valve diseases	0.002	0.998	0.000
I08.2 Disorders of both aortic and tricuspid valves	0.002	0.998	0.000
I05 Rheumatic mitral valve diseases	0.002	0.998	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
E14.5 With peripheral circulatory complications	0.000	0.998	0.002
E50.9 Vitamin A deficiency, unspecified	0.000	0.998	0.002
E50.8 Other manifestations of vitamin A deficiency	0.000	0.998	0.002
E50.7 Other ocular manifestations of vitamin A deficiency	0.000	0.998	0.002
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea	0.000	0.998	0.002
E50.5 Vitamin A deficiency with night blindness	0.000	0.998	0.002
E50.4 Vitamin A deficiency with keratomalacia	0.000	0.998	0.002
E50.3 Vitamin A deficiency with corneal ulceration and xerosis	0.000	0.998	0.002
E50.2 Vitamin A deficiency with corneal xerosis	0.000	0.998	0.002
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis	0.000	0.998	0.002
E50.0 Vitamin A deficiency with conjunctival xerosis	0.000	0.998	0.002
E64.9 Sequelae of unspecified nutritional deficiency	0.000	0.998	0.002
E64.8 Sequelae of other nutritional deficiencies	0.000	0.998	0.002
E64.3 Sequelae of rickets	0.000	0.998	0.002
E64.2 Sequelae of vitamin C deficiency	0.000	0.998	0.002
E64.1 Sequelae of vitamin A deficiency	0.000	0.998	0.002
E64.0 Sequelae of protein-energy malnutrition	0.000	0.998	0.002
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
E13.9 Without complications	0.000	0.998	0.002
E14.7 With multiple complications	0.000	0.998	0.002
E56.9 Vitamin deficiency, unspecified	0.000	0.998	0.002
E56.8 Deficiency of other vitamins	0.000	0.998	0.002
E56.0 Deficiency of vitamin E	0.000	0.998	0.002
E63.8 Other specified nutritional deficiencies	0.000	0.998	0.002
E63.1 Imbalance of constituents of food intake	0.000	0.998	0.002
E63.0 Essential fatty acid [EFA] deficiency	0.000	0.998	0.002
I24.9 Acute ischaemic heart disease, unspecified	0.002	0.998	0.000
E14.0 With coma	0.000	0.998	0.002
E63.9 Nutritional deficiency, unspecified	0.000	0.998	0.002
E15 Nondiabetic hypoglycaemic coma	0.000	0.998	0.002
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
E56.1 Deficiency of vitamin K	0.000	0.998	0.002
I05.9 Mitral valve disease, unspecified	0.002	0.998	0.000
T42.4 Benzodiazepines	0.000	0.998	0.002
T42.3 Barbiturates	0.000	0.998	0.002
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.998	0.002
E14.2 Withrenal complications	0.000	0.998	0.002
R06 Abnormalities of breathing	0.002	0.998	0.000
E14.8 With unspecified complications	0.000	0.998	0.002
E14.4 With neurological complications	0.000	0.998	0.002
E14.1 With ketoacidosis	0.000	0.998	0.002
H35.4 Peripheral retinal degeneration	0.000	0.998	0.002
H83.0 Labyrinthitis	0.002	0.998	0.000
I69 Sequelae of cerebrovascular disease	0.002	0.998	0.000
E44.1 Mild protein-energy malnutrition	0.000	0.998	0.002
E44.0 Moderate protein-energy malnutrition	0.000	0.998	0.002
H35.6 Retinal haemorrhage	0.000	0.998	0.002
I44.2 Atrioventricular block, complete	0.002	0.998	0.000
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.002	0.998	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.998	0.002
E13.3 With ophthalmic complications	0.000	0.998	0.002
H35.7 Separation of retinal layers	0.000	0.998	0.002
I50 Heart failure	0.002	0.998	0.000
E53.9 Vitamin B deficiency, unspecified	0.000	0.998	0.002
E53.1 Pyridoxine deficiency	0.000	0.998	0.002
E53.0 Riboflavin deficiency	0.000	0.998	0.002
H34.8 Other retinal vascular occlusions	0.000	0.998	0.002
I24.8 Other forms of acute ischaemic heart disease	0.002	0.998	0.000
I44.6 Other and unspecified fascicular block	0.002	0.998	0.000
R01 Cardiac murmurs and other cardiac sounds	0.002	0.998	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.998	0.002
E13.8 With unspecified complications	0.000	0.998	0.002
E13.7 With multiple complications	0.000	0.998	0.002
E13.6 With other specified complications	0.000	0.998	0.002
E13.5 With peripheral circulatory complications	0.000	0.998	0.002
E13.4 With neurological complications	0.000	0.998	0.002
E13.2 With renal complications	0.000	0.998	0.002
E13.1 With ketoacidosis	0.000	0.998	0.002
E13.0 With coma	0.000	0.998	0.002
H35.3 Degeneration of macula and posterior pole	0.000	0.998	0.002
I44.3 Other and unspecified atrioventricular block	0.002	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.002
I08.0 Disorders of both mitral and aortic valves	0.002	0.998	0.000
I31.3 Pericardial effusion (noninflammatory)	0.002	0.998	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.998	0.002
H35.1 Retinopathy of prematurity	0.000	0.998	0.002
I69.3 Sequelae of cerebral infarction	0.002	0.998	0.000
I09 Other rheumatic heart diseases	0.002	0.998	0.000
I22 Subsequent myocardial infarction	0.002	0.998	0.000
I30-I52 Other forms of heart disease	0.002	0.998	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.002
I31 Other diseases of pericardium	0.002	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.998	0.002
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.998	0.002
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.998	0.002
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.998	0.002
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
T50.8 Diagnostic agents	0.000	0.998	0.002
I07 Rheumatic tricuspid valve diseases	0.002	0.998	0.000
I06 Rheumatic aortic valve diseases	0.002	0.998	0.000
I23 Certain current complications following acute myocardial infarction	0.002	0.998	0.000
T36 Poisoning by systemic antibiotics	0.000	0.998	0.002
I60-I69 Cerebrovascular diseases	0.002	0.998	0.000
I05.1 Rheumatic mitral insufficiency	0.002	0.998	0.000
I24.1 Dressler's syndrome	0.002	0.998	0.000
I27.0 Primary pulmonary hypertension	0.002	0.998	0.000
T42.0 Hydantoin derivatives	0.000	0.998	0.002
H35.9 Retinal disorder, unspecified	0.000	0.998	0.002
H35.2 Other proliferative retinopathy	0.000	0.998	0.002
R06.5 Mouth breathing	0.002	0.998	0.000
R19.8 Other specified symptoms and signs involving the digestive system and abdomen	0.002	0.998	0.000
T40.4 Other synthetic narcotics	0.000	0.998	0.002
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.998	0.002
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.998	0.002
T42.2 Succinimides and oxazolidinediones	0.000	0.998	0.002
R14 Flatulence and related conditions	0.002	0.998	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.998	0.002
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.998	0.002
T50.1 Loop [high-ceiling] diuretics	0.000	0.998	0.002
H34 Retinal vascular occlusions	0.000	0.998	0.002
I27 Other pulmonary heart diseases	0.002	0.998	0.000
I47 Paroxysmal tachycardia	0.002	0.998	0.000
E12.9 Without complications	0.000	0.998	0.002
E12.8 With unspecified complications	0.000	0.998	0.002
E12.7 With multiple complications	0.000	0.998	0.002
E12.6 With other specified complications	0.000	0.998	0.002
E12.5 With peripheral circulatory complications	0.000	0.998	0.002
E12.4 With neurological complications	0.000	0.998	0.002
E12.3 With ophthalmic complications	0.000	0.998	0.002
E12.2 With renal complications	0.000	0.998	0.002
E12.1 With ketoacidosis	0.000	0.998	0.002
E12.0 With coma	0.000	0.998	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.002
T42.1 Iminostilbenes	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
E65-E68 Obesity and other hyperalimentation	0.000	0.998	0.002
Chapter XVIII Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified	0.002	0.998	0.000
I05.8 Other mitral valve diseases	0.002	0.998	0.000
I25.8 Other forms of chronic ischaemic heart disease	0.002	0.998	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.998	0.002
I22.1 Subsequent myocardial infarction of inferior wall	0.002	0.998	0.000
I84.2 Internal haemorrhoids without complication	0.002	0.998	0.000
R01.0 Benign and innocent cardiac murmurs	0.002	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.000	0.998	0.002
T50.7 Analeptics and opioid receptor antagonists	0.000	0.998	0.002
T50.5 Appetite depressants	0.000	0.998	0.002
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.998	0.002
T50.0 Mineralocorticoids and their antagonists	0.000	0.998	0.002
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.002
E53.8 Deficiency of other specified B group vitamins	0.000	0.998	0.001
H35.8 Other specified retinal disorders	0.000	0.998	0.002
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.002
T38.7 Androgens and anabolic congeners	0.000	0.998	0.002
T38.5 Other oestrogens and progestogens	0.000	0.998	0.002
T38.4 Oral contraceptives	0.000	0.998	0.002
T38.2 Antithyroid drugs	0.000	0.998	0.002
I36 Nonrheumatic tricuspid valve disorders	0.002	0.998	0.000
H30-H36 Disorders of choroid and retina	0.000	0.998	0.002
I05.2 Mitral stenosis with insufficiency	0.002	0.998	0.000
I27.2 Other secondary pulmonary hypertension	0.002	0.998	0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.002	0.998	0.000
K91.4 Colostomy and enterostomy malfunction	0.000	0.998	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.001
T43.9 Psychotropic drug, unspecified	0.000	0.998	0.002
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations